SCHEMBL6496926

SCHEMBL6496926

O=C1CC=C(C(=O)c2ccccc2)O1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
L3MBTL1 Q9Y468 3/20 0.41
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
SRD5A2 P31213 1/20 0.41
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
AKR1C3 P42330 1/20 0.38
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
CYP2C8 P10632 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 2/20 0.37
DAO P14920 1/20 0.37
NAPRT Q6XQN6 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
HPGD P15428 2/20 0.37
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4811175 0.69 ALDH1A1 (0.62) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL6337717 0.69 ALDH1A1 (0.70) ALDH1A1L3MBTL1ATMTDP1SRD5A2
SCHEMBL31055649 0.68 ALDH1A1 (0.48) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL28180817 0.67 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL28491203 0.67 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL1074283 0.67 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL6061130 0.67 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL30536983 0.67 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL30537001 0.67 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2
Benzophenone SCHEMBL17745 0.67 ALDH1A1 (1.00) ALDH1A1L3MBTL1ATMTDP1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113366-A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses UNIVERSITE LOUIS PASTEUR (ETABLISSEMENT PUBLIC A CARACTERE SCIENTIFIQUE, CULTUREL ET PROFESSIONNEL) (FR) 2005-05-26 US disclosed
CN-1258300-A Modified benzimidazole nucleosides as antiviral agents UNIV MICHIGAN (US) 2000-06-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113366-A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses GABRB1, GABRA1, GABRA5 ALDH1A1 590/4885L3MBTL1 2407/4885ATM 4423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.